Conti DV - Search Results

1

Comprehensive evaluation of ESR2 variation and ovarian cancer risk.

Leigh Pearce C, Near AM, Butler JL, Van Den Berg D, Bretsky P, Conti DV, Stram DO, Pike MC, Hirschhorn JN, Wu AH. Leigh Pearce C, et al. Among authors: conti dv. Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):393-6. doi: 10.1158/1055-9965.EPI-07-2512. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18268123

2

CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer.

Plummer SJ, Conti DV, Paris PL, Curran AP, Casey G, Witte JS. Plummer SJ, et al. Among authors: conti dv. Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):928-32. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14504207

3

Bayesian spatial modeling of haplotype associations.

Thomas DC, Stram DO, Conti D, Molitor J, Marjoram P. Thomas DC, et al. Hum Hered. 2003;56(1-3):32-40. doi: 10.1159/000073730. Hum Hered. 2003. PMID: 14614236

4

Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness.

Cicek MS, Nock NL, Li L, Conti DV, Casey G, Witte JS. Cicek MS, et al. Among authors: conti dv. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1331-6. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298954

5

SNPs, haplotypes, and model selection in a candidate gene region: the SIMPle analysis for multilocus data.

Conti DV, Gauderman WJ. Conti DV, et al. Genet Epidemiol. 2004 Dec;27(4):429-41. doi: 10.1002/gepi.20039. Genet Epidemiol. 2004. PMID: 15543635

6

Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.

Cozen W, Gebregziabher M, Conti DV, Van Den Berg DJ, Coetzee GA, Wang SS, Rothman N, Bernstein L, Hartge P, Morhbacher A, Coetzee SG, Salam MT, Wang W, Zadnick J, Ingles SA. Cozen W, et al. Among authors: conti dv. Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2285-91. doi: 10.1158/1055-9965.EPI-06-0446. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17119059

7

XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.

Stern MC, Siegmund KD, Conti DV, Corral R, Haile RW. Stern MC, et al. Among authors: conti dv. Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2384-90. doi: 10.1158/1055-9965.EPI-06-0381. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17164360

8

Testing association between disease and multiple SNPs in a candidate gene.

Gauderman WJ, Murcray C, Gilliland F, Conti DV. Gauderman WJ, et al. Among authors: conti dv. Genet Epidemiol. 2007 Jul;31(5):383-95. doi: 10.1002/gepi.20219. Genet Epidemiol. 2007. PMID: 17410554

9

Alcohol consumption and risk of bladder cancer in Los Angeles County.

Jiang X, Castelao JE, Groshen S, Cortessis VK, Ross RK, Conti DV, Gago-Dominguez M. Jiang X, et al. Among authors: conti dv. Int J Cancer. 2007 Aug 15;121(4):839-45. doi: 10.1002/ijc.22743. Int J Cancer. 2007. PMID: 17440923

10

DNA repair single-nucleotide polymorphisms in colorectal cancer and their role as modifiers of the effect of cigarette smoking and alcohol in the Singapore Chinese Health Study.

Stern MC, Conti DV, Siegmund KD, Corral R, Yuan JM, Koh WP, Yu MC. Stern MC, et al. Among authors: conti dv. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2363-72. doi: 10.1158/1055-9965.EPI-07-0268. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18006925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters